Activity value 72china Buyer&Supplier,Last transaction date:
2026-06-09
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shandong lixin pharmaceutical co ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 12 transactions, with a transaction quantity of 1320 and a transaction weight of 160.
YearTransactionsQuantityWeight
20255021027.07370.2
2026121320160
Bill of lading data
<
1/15
>
Trade date
2026/06/09
B/L No.
——
Suppliers
shandong lixin pharmaceutical co ltd.
Buyers
oncogen pharma
POLs
——
PODs
kpaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
88606.625943
Hs code
29335990
Product tags
pharmaceutical raw material,nilotinib hydrochloride monohydrate
Product description
PHARMACEUTICAL RAW MATERIAL NILOTINIB HYDROCHLORIDE MONOHYDRATE
Expand
Trade date
2026/06/08
B/L No.
——
Suppliers
shandong lixin pharmaceutical co ltd.
Buyers
healthcare pharmaceuticals
shandong lixin pharmaceutical co ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as methyl,deoxy,acetyl.
According to the 52wmb.com global trade database, as of 2026-06-09, the company has completed 139 international trades,
with its main trading regions covering india,pakistan,bangladesh etc.
The core products include HS29335990,HS29349990,HS29332990 etc,
often transported via china,port beijing etc,
and its main trading partners are vannsh life sciences pvt ltd.,oncogen pharma,renata ltd. change from pfizer.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shandong lixin pharmaceutical co ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.